Loss of runt-related transcription factor 3 expression associated with human hepatocellular carcinoma progression and prognosis

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 9, 2011, Pages 2285-2290

  Li, Jianguo ^a   Jiang, Xiaojie ^b  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b PUTIAN UNIVERSITY   (China)

Author keywords

Fluorescent quantitative PCR; Gene expression; HCC; Runt related transcription factor 3

Indexed keywords

MESSENGER RNA; RUNX3 PROTEIN, HUMAN; TRANSCRIPTION FACTOR RUNX3;

ARTICLE; BIOSYNTHESIS; CELL LINE; DISEASE COURSE; DOWN REGULATION; FEMALE; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL LINE, TUMOR; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RNA, MESSENGER;

EID: 84865113226     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Araki K, Osaki M, Nagahama Y, et al (2005). Expression of RUNX3 protein in human lung adenocarcinoma: implications for tumor progression and prognosis. Cancer Sci, 96, 227-31.
2. Bangsow C, Rubins N, Glusman G, et al (2001). The RUNX3 gene-sequence, structure and regulated expression. Gene, 279, 221-32.
3. Chi XZ, Yang JO, Lee KY, et al (2005). RUNX3 suppresses gastric epithelial cell growth by inducing p21 (WAF/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD. Mol Cell Biol, 25, 8097-107.
4. EI Serag HB, Rudolph KL (2007). Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterol, 132, 2557-76.
5. Goel A, Arnold CN, Tassone P, et al (2004). Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers. Int J Cancer, 112, 254-9.
6. He JF, Ge MH, Zhu X, et al (2008). Expression of RUNX3 in salivary adenoid cystic carcinoma: Implications for tumor progression and prognosis. Cancer Sci, 99, 1334-40.
7. Hussenet T, Han W, Bae JY, et al (2007). Downregulation of the RUNX3 gene by promoter hypermethylation and hemizygous deletion in breast cancer. J Korean Med Sci, 22, 24-31.
8. Imamura Y, Hibi K, Koike M, et al (2005). RUNX3 promoter region is specifically methylated in poorly-differentiated colorectal cancer. Anticancer Res, 25, 2627-30.
9. Ito Y, Miyazono K (2003). RUNX transcription factors as key targets of TGF-β superfamily signaling. Curr Opin Genet Dev, 13, 43-7.
10. Jiang Y, Tong DD, Lou G, et al (2008). Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines. Pathobiology, 75, 244-51.
11. Kudo Y Tsunematsu T, Takata T (2011). Oncogenic role of RUNX3 in head and neck cancer. J Cell Biochem, 112, 383-93.
12. Lee YM (2011). Control of RUNX3 by histone methyltransferases. J Cell Biochem, 112, 394-400.
13. Li QL, Ito K, Sakakura C, et al (2002). Causal relationship between of the loss of RUNX3 expression and gastric cancer. Cell, 109, 113-24.
14. Li X, Zhang Y, Zhang Y, et al (2008). RUNX3 inhibits growth of HCC cells and HCC xenografts in mice in combination with adriamycin. Cancer Biol Ther, 7, 669-76.
15. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression datausing real-time quantitative PCR and the 2-Ct method. Methods, 25, 402-8.
16. Miyazono K, Suzuki H, Imamura T (2003). Regulation of TGF-beta signaling and its roles in progression of tumor. Cancer Sci, 94, 230-4.
17. Mori T, Nomoto S, Koshikawa K, et al (2005). Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma. Liver Int, 25, 380-8.
18. Nakanishi Y, Shiraha H, Nishina S, et al (2011). Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis. BMC Cancer, 11, 3.
19. Sakakura C, Hasegawa K, Miyagawa K, et al (2005). Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers. Clin Cancer Res, 11, 6479-88.
20. Shiraha H, Nishina S, Yamamoto K (2011). Loss of runt-related transcription factor 3 causes development and progression of hepatocellular carcinoma. J Cell Biochem, 112, 745-9.
21. Tsunematsu T, Kudo Y, Iizuka S, et al (2009). RUNX3 has an oncogenic role in head and neck cancer. PLoS One, 4, e5892.
22. Wei D, Gong W, Oh SC, et al (2005). Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis. Cancer Res, 65, 4809-16.
23. Zhang S, Li ZF, Pan D, et al (2009). Changes of splenic macrophage during the process of liver cancer induced by diethylnitrosamine in rats. Chin Med J, 122, 3043-7.